• In late April 2026, Procter & Gamble reported third-quarter fiscal 2026 results showing sales of US$21,235 million and net income of US$3,932 million, alongside reaffirmed full-year guidance for modest all-in sales and diluted EPS growth.
• These results, combined with P&G’s 70th consecutive annual dividend increase and ongoing product launches in categories like air care and haircare, underline how the company is pairing steady cash returns with continued brand innovation.
• With P&G’s earnings strength and 70-year dividend growth streak now confirmed, we’ll examine how this affects its pre-existing investment narrative.

AI is about to change healthcare. These 32 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

Procter & Gamble Investment Narrative Recap

To own Procter & Gamble, you generally have to believe in its ability to turn a portfolio of everyday brands into durable cash generation, even when costs and demand are choppy. The latest quarter’s higher sales and earnings, alongside reaffirmed guidance, support that view near term, while the key short term catalyst remains consistent organic growth across regions. The biggest risk still looks like external cost and geopolitical pressures that could squeeze margins if they intensify, and this update does not materially change that.

The fresh product launches under brands like Febreze and Aussie are relevant here because they show how P&G is trying to support that organic growth catalyst with incremental innovation in categories such as air care and haircare. The new Febreze TRASH Odor Fighter, now on shelves at major US retailers, is a concrete example of P&G looking to extend familiar brands into new usage occasions, which may help underpin category volumes if consumer spending stays uneven.

Yet even with steady results and a 70 year dividend growth streak, investors still need to be aware of how sustained geopolitical and cost pressures could...

Procter & Gamble's narrative projects $93.9 billion revenue and $18.3 billion earnings by 2029.

Uncover how Procter & Gamble's forecasts yield a $164.18 fair value, a 10% upside to its current price.

Exploring Other Perspectives

Twenty members of the Simply Wall St Community currently see fair value for P&G between US$121.06 and US$196.74, reflecting a wide spread of individual views. Set against that, the reaffirmed guidance and ongoing exposure to geopolitical and cost risks give you several different angles to consider for how the business might perform over time.

Explore 20 other fair value estimates on Procter & Gamble - why the stock might be worth as much as 32% more than the current price!

Reach Your Own Conclusion

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Procter & Gamble research is our analysis highlighting 4 key rewards and 2 important warning signs that could impact your investment decision.
• Our free Procter & Gamble research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Procter & Gamble's overall financial health at a glance.

No Opportunity In Procter & Gamble?

The market won't wait. These fast-moving stocks are hot now. Grab the list before they run:

• Find 53 companies with promising cash flow potential yet trading below their fair value.
• We've uncovered the 14 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
• Uncover the next big thing with 24 elite penny stocks that balance risk and reward.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.